Company Filing History:
Years Active: 2025
Title: Li Wang - Innovator in ADC Detection Methods
Introduction
Li Wang is a prominent inventor based in Yantai, China. He has made significant contributions to the field of analytical chemistry, particularly in the detection of TCEP content in antibody-drug conjugates (ADCs). His innovative approach has garnered attention for its specificity and efficiency.
Latest Patents
Li Wang holds a patent for a method titled "Method for detecting TCEP content in ADC by LC-MS/MS." This method involves the derivatization of ADC samples through the Ellman reaction, followed by measurement of TCEP content using LC-MS/MS. The technique effectively eliminates interference from substances that may react with Ellman in complex ADC samples, thus providing a streamlined process without the need for sample pretreatment.
Career Highlights
Li Wang is currently employed at Remegen Co., Ltd., where he continues to advance research in the field of drug development. His work has been instrumental in enhancing the accuracy of ADC analysis, which is crucial for the development of targeted therapies.
Collaborations
Li Wang collaborates with notable colleagues, including Xuejing Yao and Wenlong Sun, who contribute to the innovative research environment at Remegen Co., Ltd. Their combined expertise fosters a culture of creativity and scientific advancement.
Conclusion
Li Wang's contributions to the detection of TCEP content in ADCs exemplify the impact of innovative methodologies in the pharmaceutical industry. His work not only enhances analytical precision but also paves the way for future advancements in drug development.